Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-004. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-005. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GI.P5-GI.5/NV-23-006. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GI.P3-GI.3/NV-23-007
. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P7-GII.6/NV-23-008.
. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.10/NV-23-009.
. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P8-GII.8/NV-23-010.
. Material 10-20% fecal material in virus culture medium.
Human influenza A(H1N1)pdm09 virus isolated in 2022/2023 season in Greece. Infectious cell culture supernatant preserved in Viral Storage Medium -80°C.
P1 cultured virus from a monkey pox positive patient.
First Dutch isolate from MPXV infected patient.
NOTE: This material is not available for commercial purposes, such as contract research services”